DNA extraction by FTA™ technology: Application for rapid detection of 1p/19q deletions in gliomas

Neuropathology and Applied Neurobiology

Volumn 33, Issue 3, 2007, Pages 360-363

  Fontaine, D ^a   Monnot, S ^b   Vandenbos, F ^a   Paquis, P ^a   Michiels, J F ^a   Bannwarth, S ^b   Lebrun, ^a   Bourg, ^a   Chatel, ^a   Lonjon, ^a   Chanalet, ^a   Ramaioli, ^c   Courdi, ^c   Frenay, ^c   Paquis Flucklinger, V ^d  

^a PASTEUR HOSPITAL   (France)

^b CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^c CENTRE ANTOINE LACASSAGNE   (France)

^d UNIVERSITÉ CÔTE D'AZUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MICROSATELLITE DNA;

ASTROCYTOMA; BLOOD SAMPLING; BRAIN BIOPSY; CHROMOSOME DELETION; CONTROLLED STUDY; DNA EXTRACTION; EVALUATION; GLIOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; LETTER; MAJOR CLINICAL STUDY; MICROSATELLITE MARKER; OLIGODENDROGLIOMA; PRIORITY JOURNAL; SAMPLING; STEREOTAXIC SURGERY;

BRAIN NEOPLASMS; DNA; GENE DELETION; GENETIC TECHNIQUES; GLIOMA; HUMANS; MICROSATELLITE REPEATS; POLYMERASE CHAIN REACTION;

EID: 34247869079     PISSN: 03051846     EISSN: 13652990     Source Type: Journal    
DOI: 10.1111/j.1365-2990.2007.00835.x     Document Type: Letter

References (11)

1. Smith J, Jenkins R. Genetic alterations in adult diffuse glioma: occurrence, significance and prognostic implications. Front Biosci 2000 5 : d213 231
2. Kleihues P, Cavenee W. Pathology and Genetics of Tumours of the Nervous System. Lyon : IARC Press, 2000
3. Jeuken J, von Deimling A, Wesseling P. Molecular pathogenesis of oligodendroglial tumors. J Neurooncol 2004 70 : 161 81
4. van den Bent M, Carpentier A, Brandes A, Sanson M, Taphoorn M, Bernsen H, Frenay M, Tijssen C, Grisold W, Sipos L, Haaxma-Reiche H, Kros J, van Kouwenhoven M, Vecht C, Allgeier A, Lacombe D, Gorlia T. Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Cancer phase III trial. J Clin Oncol 2006 24 : 2715 22
5. Cairncross J, Berkey B, Shaw E, Jenkins R, Scheithauer B, Brachman D, Buckner J, Fink K, Souhami L, Laperierre N, Mehta M, Curran W. Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: intergroup radiation therapy oncology group trial 9402. J Clin Oncol 2006 24 : 2707 14
6. Ino Y, Betensky R, Zlatescu M, Sasaki H, McDonald D, Stemmer-Rachamimov A, Ramsay D, Cairncross J, Louis D. Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis. Clin Cancer Res 2001 7 : 839 45
7. Myal Y, Del Bigio M, Rhodes R. Age-related differences in 1p and 19q deletions in oligodendrogliomas. BMC Clin Pathol 2003 3 : 6
8. Coons S, Johnson P, Scheithauer B, Yates A, Pearl D. Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas. Cancer 1997 79 : 1381 93
9. Smith L, Burgoyne L. Collecting, archiving and processing DNA from wildlife samples using FTA databasing paper. BMC Ecol 2004 4 : 4
10. von Knobloch R, Hegele A, Brandt H, Varga Z, Wille S, Kable T, Heidenreich A, Hofmann R. High frequency of serum DNA alterations in renal cell carcinoma detected by fluorescent microsatellite analysis. Int J Cancer 2002 98 : 889 94
11. Hatanpaa K, Burger P, Eshleman J, Murphy K, Berg K. Molecular diagnosis of oligodendroglioma in paraffin sections. Lab Invest 2003 83 : 419 28